ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Program Project Guidelines Available

October 27, 1995

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976

Program Announcements. RAPID Program Date Change.

June 29, 2001

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center

August 1, 1997